Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
a) | Name |
Steven Bates | ||||
2 | Reason for the notification | |||||
a) | Position/status |
Non-executive Director | ||||
b) | Initial notification /Amendment |
Initial notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name |
The Biotech Growth Trust PLC | ||||
b) | LEI |
549300Z41EP32MI2DN29 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
a) | Description of the financial instrument, type of instrument Identification code |
Ordinary 25p shares GB0000385517 |
||||
b) | Nature of the transaction |
Purchase for own account | ||||
c) | Price(s) and volume(s) |
|
||||
d) | Aggregated information - Aggregated volume - Price |
10,000 ordinary 25p shares 715.0 pence per share |
||||
e) | Date of the transaction |
26 May 2017 | ||||
f) | Place of the transaction |
London Stock Exchange (XLON) |
Name of authorised official of issuer responsible for making notification:
Mark Pope, for and on behalf of Frostrow Capital LLP
Company Secretary to THE BIOTECH GROWTH TRUST PLC